CRNX — CRINETICS PHARMACEUTICALS IN
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 277 家机构在其最新 13F 申报中持有 CRNX(CRINETICS PHARMACEUTICALS IN),合计申报市值 $5.29B,对应 147.66M 股。按股数计算较上季度增持 2.9%(+3.89M 股),申报市值环比上升 5.5%。持仓集中度较高:前五大持有人占申报市值的 35.9%,前十大的集中度为 56.6%。
与上一季度相比,59 家新建仓位、99 家加仓、69 家减仓、35 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
CRINETICS PHARMACEUTICALS IN(CRNX)的主要机构持有人包括 Fidelity Management & Research (FMR)、Vanguard Group、BlackRock Inc,按 13F 申报市值在本页 507 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 3 | 13.19K | $563.17K | +7.8% |
| Q2 2026 | 277 | 147.66M | $5.29B | +2.9% |
| Q1 2026 | 253 | 145.18M | $5.08B | +11.7% |
| Q4 2025 | 253 | 133.25M | $5.96B | +6.1% |
| Q3 2025 | 229 | 126.14M | $5.03B | +4.7% |
| Q2 2025 | 221 | 120.97M | $3.32B | +1.3% |
| Q1 2025 | 225 | 119.03M | $3.82B | +2.8% |
| Q4 2024 | 245 | 115.97M | $5.65B | +23.4% |
表内 8 个季度中,机构持股合计减少 100%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2024(+23.4%)。
前 25 大机构持仓人(Q3 2026) — 3 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 10.64K | $398.00K | 0.00% | 持有 | |
| 1.47K | $124.54K | 0.00% | 增持 | |
| 1.09K | $40.64K | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- Jupiter Topco LLC 4.56M 股 · $170.51M
- GEODE CAPITAL MANAGEMENT, LLC 2.73M 股 · $102.09M
- Polar Capital Holdings Plc 2.27M 股 · $85.11M
- Sixth Street Partners Management Company, L.P. 877.64K 股 · $32.84M
- KENNEDY CAPITAL MANAGEMENT LLC 365.71K 股 · $13.69M
- Defilade Capital Management, L.P. 239.44K 股 · $8.96M
- Foresite Capital Management IV, LLC 150.00K 股 · $5.61M
- Ishara Investments LP 143.50K 股 · $5.37M
- Odyssean, LLC 84.46K 股 · $3.16M
- ExodusPoint Capital Management, LP 70.88K 股 · $2.65M
- Swedbank AB 59.60K 股 · $2.23M
- Longaeva Partners L.P. 58.39K 股 · $2.18M
完全清仓(较上季)
- Janus Henderson Group 卖出 4.52M 股 · $164.23M
- EcoR1 Capital, LLC 卖出 4.29M 股 · $155.74M
- STATE STREET CORP 卖出 2.40M 股 · $87.28M
- RTW INVESTMENTS, LP 卖出 1.45M 股 · $52.71M
- Sio Capital Management, LLC 卖出 249.89K 股 · $9.08M
- Connor, Clark & Lunn Investment Management Ltd. 卖出 79.75K 股 · $2.90M
- Millennium Management 卖出 62.37K 股 · $2.27M
- MILLENNIUM MANAGEMENT LLC 卖出 62.37K 股 · $2.27M
- TUDOR INVESTMENT CORP ET AL 卖出 46.02K 股 · $1.67M
- Checkpoint Capital L.P. 卖出 40.23K 股 · $1.46M
- CAPITAL FUND MANAGEMENT S.A. 卖出 30.73K 股 · $1.12M
- Progeny 3, Inc. 卖出 24.00K 股 · $871.68K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TEACHER RETIREMENT SYSTEM OF TEXAS | 10.64K | 10.64K | 11.51K | 13.22K | 21.77K | 23.78K | 22.44K | 24.00K | 16.81K | 14.55K | 14.00K | 12.20K | 13.86K | — | — | — | — | — | — | — |
| IFP Advisors, Inc | 1.47K | 1.44K | 1.44K | 1.45K | 1.45K | 1.35K | 1.44K | 1.46K | 1.42K | 1.48K | 1.49K | — | — | — | — | — | — | — | — | — |
| Allworth Financial LP | 1.09K | 159 | 239 | 252 | 220 | 135 | 5 | 9 | 24 | 30 | 20 | 20 | 48 | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | 15.84M | 15.76M | 14.29M | 14.19M | 14.13M | 14.03M | 8.93M | 4.46M | 4.10M | 4.46M | 4.04M | 2.14M | 1.08M | 920.96K | 1.88M | 2.68M | 2.99M | 3.34M | 3.72M |
| Vanguard Group | — | — | — | 9.14M | 9.17M | 9.26M | 9.31M | 9.09M | 6.29M | 4.51M | 3.58M | 3.50M | 3.41M | 2.73M | 2.69M | 2.39M | 2.36M | 2.44M | 2.10M | 2.10M |
| BlackRock Inc | — | 9.76M | 8.48M | 7.99M | 7.59M | 7.42M | 7.66M | 7.52M | 6.55M | — | — | — | — | — | — | — | — | — | — | — |
| Wellington Management Group | — | 7.13M | 8.16M | 8.04M | 8.38M | 5.81M | 6.89M | 6.95M | 4.46M | 4.62M | 2.97M | 3.25M | 3.64M | 3.60M | 3.64M | 2.80M | 2.63M | 1.82M | 1.03M | 1.07M |
| WELLINGTON MANAGEMENT GROUP LLP | — | 7.13M | 8.16M | 8.04M | 8.38M | 5.81M | 6.89M | 6.95M | 4.46M | 4.62M | 2.97M | 3.25M | 3.64M | — | — | — | — | — | — | — |
| Farallon Capital Management | — | 8.99M | 8.34M | 6.93M | 5.77M | 4.65M | 4.61M | 4.08M | 1.16M | 497.00K | 5.00K | 122.90K | 361.90K | — | — | — | — | — | — | — |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | — | 8.99M | 8.34M | 6.93M | 5.77M | 4.65M | 4.61M | 4.08M | 1.16M | 497.00K | 5.00K | 122.90K | 361.90K | — | — | — | — | — | — | — |
| DRIEHAUS CAPITAL MANAGEMENT LLC | — | 6.46M | 6.40M | 6.39M | 6.48M | 6.40M | 6.24M | 6.14M | 5.89M | 6.11M | 5.23M | 5.04M | 5.13M | — | — | — | — | — | — | — |
| PRICE T ROWE ASSOCIATES INC /MD/ | — | 6.21M | 5.36M | 5.22M | 5.31M | 5.59M | 5.11M | 5.41M | 4.94M | 4.41M | 3.82M | 3.01M | 2.58M | — | — | — | — | — | — | — |
| Point72 Asset Management | — | 46.38K | — | 2.34M | 2.00M | 2.00M | 778.40K | 2.79M | 2.30M | 2.78M | 4.95M | 3.42M | 4.23M | — | 226.40K | 1.36M | 1.31M | 1.33M | 1.21M | 1.10M |
| EcoR1 Capital, LLC | — | — | 4.29M | 4.29M | 4.29M | 4.29M | 4.29M | 4.29M | 4.29M | 4.16M | 4.16M | 2.01M | 1.53M | — | — | — | — | — | — | — |
| Janus Henderson Group | — | — | 4.52M | 4.44M | 3.86M | 3.41M | 3.42M | 2.80M | 2.43M | 2.46M | 1.98M | 543.26K | 588.38K | 470.74K | 416.25K | 406.26K | 189.85K | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | — | 4.83M | 4.64M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | — | 4.75M | 4.67M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jupiter Topco LLC | — | 4.56M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | — | — | 2.40M | 2.16M | 2.21M | 3.22M | 3.28M | 2.99M | 2.84M | 2.81M | 3.26M | 3.56M | 2.85M | — | — | — | — | — | — | — |
| Paradigm Biocapital Advisors LP | — | — | — | 2.21M | 2.55M | 2.34M | 1.95M | 1.91M | 2.52M | 2.51M | 3.12M | 2.31M | 2.18M | — | — | — | — | — | — | — |
常见问题
Which funds hold CRNX?
As of 2026-Q2, 277 institutional funds reported holding CRNX (CRINETICS PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $5.29B.
How many shares of CRNX do institutions own?
13F filers reported 147.66M shares of CRNX, worth $5.29B in aggregate at the end of 2026-Q2.
Is institutional ownership of CRNX rising or falling?
Share counts moved +2.9% versus the prior quarter — accumulation.
Who are the top institutional holders of CRNX?
The largest 13F holders are Fidelity Management & Research (FMR), Vanguard Group, BlackRock Inc, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C.; the top 25 are ranked at the top of this page.
Who are the major shareholders of CRINETICS PHARMACEUTICALS IN?
The major shareholders of CRINETICS PHARMACEUTICALS IN (CRNX) by reported 13F value are Fidelity Management & Research (FMR), Vanguard Group, BlackRock Inc, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 507 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.